| Authors: |
Llewellyn AM; Translational Pathology, Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., D'Costa SL; Synnovis, Department of Cellular Pathology, a partnership between SYNLAB UK & Ireland, Guy's and St Thomas' NHS Foundation Trust, and King's College Hospital NHS Foundation Trust, London, UK., Lam CY; Synnovis, Department of Cellular Pathology, a partnership between SYNLAB UK & Ireland, Guy's and St Thomas' NHS Foundation Trust, and King's College Hospital NHS Foundation Trust, London, UK., Gore JA; Translational Pathology, Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Lachina V; Stromal Immunology Group, Laboratory for Molecular Cell Biology, University College London, London, UK., Shewring DJ; Stromal Immunology Group, Laboratory for Molecular Cell Biology, University College London, London, UK., Acton SE; Stromal Immunology Group, Laboratory for Molecular Cell Biology, University College London, London, UK., Naidoo K; Translational Pathology, Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.; Department of Cellular Pathology, King's College Hospital, London, UK. |
